Skip to main content

Home/ MaRS/ Group items tagged OncoTek

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Assunta Krehl

OICR invests $1 million in the further development of two new cancer treatments - Canad... - 0 views

www.newswire.ca/...c8969.html

OncoTek Ontario Institute for Cancer Research Clients & Tenants

shared by Assunta Krehl on 15 Mar 10 - Cached
  • Assunta Krehl on 15 Mar 10
     
    Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) announced an investment of $1 million towards the development of two new promising cancer therapies. OncoTek Drug Delivery Inc (a subsidiary of Receptor Therapeutics) is one of the recipients.
1 - 1 of 1
Showing 20▼ items per page